Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1878-7479
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies ; day:28 ; month:3 ; year:2022 ; pages:1-11
Neurotherapeutics ; (28.3.2022), 1-11
- Urheber
-
Briani, Chiara
Visentin, Andrea
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13311-022-01222-x
- URN
-
urn:nbn:de:101:1-2022061807492894893027
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Briani, Chiara
- Visentin, Andrea
- SpringerLink (Online service)
Ähnliche Objekte (12)
Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies
Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells
Characteristics of A-waves in patients with amyotrophic lateral sclerosis (ALS) versus demyelinating neuropathies (DN)
Antibody Therapies in Autoimmune Encephalitis
Diabetic Neuropathies
Stem cell therapies for autoimmune hepatitis
Antibody-mediated initiation and lymphocyte-targeting therapies in CNS demyelinating disease
High-dose pharmaceutical-grade biotin in patients with demyelinating neuropathies: a phase 2b open label, uncontrolled, pilot study
Multiple Cranial Neuropathies
Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease
Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease
Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies
Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells
Characteristics of A-waves in patients with amyotrophic lateral sclerosis (ALS) versus demyelinating neuropathies (DN)
Antibody Therapies in Autoimmune Encephalitis
Diabetic Neuropathies
Stem cell therapies for autoimmune hepatitis
Antibody-mediated initiation and lymphocyte-targeting therapies in CNS demyelinating disease
High-dose pharmaceutical-grade biotin in patients with demyelinating neuropathies: a phase 2b open label, uncontrolled, pilot study
Multiple Cranial Neuropathies
Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease
Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease
Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies
Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells
Characteristics of A-waves in patients with amyotrophic lateral sclerosis (ALS) versus demyelinating neuropathies (DN)
Antibody Therapies in Autoimmune Encephalitis
Diabetic Neuropathies
Stem cell therapies for autoimmune hepatitis
Antibody-mediated initiation and lymphocyte-targeting therapies in CNS demyelinating disease
High-dose pharmaceutical-grade biotin in patients with demyelinating neuropathies: a phase 2b open label, uncontrolled, pilot study
Multiple Cranial Neuropathies
Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease
Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease